We are witnessing the evolution of the diagnostic imaging that is rapidly becoming available to Women’s Health physicians (OB/GYN’s), enabling the use of technology to augment our ability to medically palpate on examination of the patient, to identify conditions which we were unable to appreciate a short time ago. Threedimensional transvaginal sonography (3DTVS), along with power Doppler angiography (PDA), are examples of such technologies. Clinicians have long appreciated the ability to view a three-dimensional image from the use of X-Rays (e.g. in computed tomography [CT] scans), or with magnetic resonance imaging (MRI). We can now create 3-D images with the use of ultrasound, in an easier and less costly way, and with possibly lesser harmful radiation. The tissue which is an ideal target of this imaging is found in the pelvis. Naturally, looking at the uterus, fallopian tubes, and ovaries is within the province of the OB/GYN.

There are many examples of the diagnostic utility of 3DTVS in OB/GYN. For example, identification of an embedded, broken or partially expelled intrauterine contraceptive device (IUD) is now possible [1], which can help to lead to resolution of that clinical problem (Figure 1). The identification of deep infiltrating endometriosis (DIE), not able to be seen laparoscopically, is also possible with the use of 3DTVS (Figure 2) [2]. The practical imaging of benign leiomyomata (i.e. fibroids) is often used to monitor their growth, with the caliper measurement of size, aiding decision-making regarding the possible need for surgical intervention (Figure 3) [1]. The identification of uterine malformations is also possible today, at times explaining the etiology of pregnancy loss and fertility failure (Figure 4). With the ability to identify vascular flow, identification and staging of endometrial carcinoma has even been recently demonstrated (Figure 5) [3]. We have been actively using ultrasound (US) to help diagnose ectopic pregnancy (EP), but 3DTVS may aid the diagnosis further with characterization of its vascular flow with the use of 3DTVS and PDA [1]. Obviously, we are still early in discovering the clinical benefit of this imaging technology.

We are sure to see the future evolution of the use of ultrasound imaging in this specialty, with even greater expansion of technology, in currently unimaginable ways. A few rendering 3D images accompanying this message illustrates the sort of image resolution and clinical benefit that is possible.